US 7,332,494 B2
Method for treating allergies using substituted pyrazoles
J. Guy Breitenbucher, Escondido, Calif. (US); Hui Cai, San Diego, Calif. (US); James P. Edwards, San Diego, Calif. (US); Cheryl A. Grice, Carlsbad, Calif. (US); Yin Gu, San Diego, Calif. (US); Darin J. Gustin, Half Moon Bay, Calif. (US); Lars Karlsson, La Jolla, Calif. (US); Haripada Khatuya, San Diego, Calif. (US); Steven P. Meduna, San Diego, Calif. (US); Barbara A. Pio, Hillsborough, N.J. (US); Siquan Sun, San Diego, Calif. (US); Kevin L. Tays, Cardiff by the Sea, Calif. (US); Robin L. Thurmond, San Diego, Calif. (US); and Jianmei Wei, San Diego, Calif. (US)
Assigned to Janssen Pharmaceutica, N.V., Beerse (Belgium)
Filed on Feb. 13, 2002, as Appl. No. 10/75,673.
Application 10/075673 is a continuation in part of application No. 09/928122, filed on Aug. 10, 2001.
Claims priority of provisional application 60/230407, filed on Sep. 06, 2000.
Claims priority of provisional application 60/225138, filed on Aug. 14, 2000.
Prior Publication US 2003/0069240 A1, Apr. 10, 2003
Int. Cl. A61K 31/497 (2006.01); A61K 31/50 (2006.01); A61K 31/53 (2006.01); A61K 31/505 (2006.01)
U.S. Cl. 514—252.13  [514/252.12; 514/252.14; 514/252.01; 514/241; 514/256; 514/269] 2 Claims
OG exemplary drawing
 
1. A method for treating a subject with an allergic condition, said method comprising administering to the subject a therapeutically effective amount of a pharmaceutical composition comprising the compound:
1-[3-(3,4-Dichloro-phenyl)-pyrazol-1-yl]-3-(4-o-tolyl-piperazin-1-yl)-propan-2-ol.